Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xingguo Quan"'
Autor:
Jiwon Shin, Min-Jung Kim, Xingguo Quan, Ji Woong Kim, Sukmook Lee, SaeGwang Park, Jee-Yeong Jeong, Kyungmoo Yea
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-15 (2023)
Abstract Background Thrombocytopenia is a common complication in cancer patients undergoing chemotherapy. Chemotherapy-induced thrombocytopenia (CIT) leads to dose reduction and treatment delays, lowering chemotherapy efficacy and survival rate. Thus
Externí odkaz:
https://doaj.org/article/222b3bc5d3984688ac61621c2d8c6081
Autor:
Xingguo Quan1, Ji-Young Lee2, Jin Hee Park1, Haque, Md. Masudul1, Hee Yeon Kim3, Ilhwan Kim4, Anbok Lee3, Il-Whan Choi1, SaeGwang Park1 micpsg@inje.ac.kr
Publikováno v:
Pharmacognosy Research. Jul-Sep2021, Vol. 13 Issue 3, p165-172. 8p.
Autor:
Anbok Lee, Xingguo Quan, Jin-Hee Park, Il-Whan Choi, Md. Masudul Haque, Hee Yeon Kim, Ji Young Lee, Il Hwan Kim, Sae-Gwang Park
Publikováno v:
Pharmacognosy Research. 13:165-172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53a0c6a1068a8b6b43b89c613e096d4d
https://doi.org/10.5530/pres.13.3.9
https://doi.org/10.5530/pres.13.3.9
Autor:
Jiwon Shin, Min-Jung Kim, Xingguo Quan, Ji Woong Kim, Sukmook Lee, SaeGwang Park, Jee-Yeong Jeong, Kyungmoo Yea
Background Thrombocytopenia is a common complication in cancer patients undergoing chemotherapy. Chemotherapy-induced thrombocytopenia (CIT) leads to dose reduction and treatment delays, lowering chemotherapy efficacy and survival rate. Thus, rapid r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5551bf29e1935f781ccfd9348473e566
https://doi.org/10.21203/rs.3.rs-2115554/v1
https://doi.org/10.21203/rs.3.rs-2115554/v1
Autor:
Anbok Lee, Jin-Hee Park, Ji Young Lee, Beom Seok Kwak, Xingguo Quan, Tae Hyun Kim, Sae-Gwang Park
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2020 (2020)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Cordyceps militaris has been widely used as a traditional medicine in East Asia. Its effects against breast cancer have been reported previously. However, whether C. militaris-induced breast cancer cell death is immunogenic remains unelucidated. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0be81ff6660c0d1b463f8eabe433fe3b
https://doi.org/10.1155/2020/9053274
https://doi.org/10.1155/2020/9053274
Autor:
Hye Kyoung Yoon, SaeGwang Park, Anbok Lee, Tae Hyun Kim, Seung Jae Park, Hana Jung, Xingguo Quan, Jaewoong Han
Publikováno v:
Pathology, research and practice. 214(10)
This study identified chemotherapeutic agents that up-regulate programmed cell death ligand-1 (PD-L1) and galectin-9 (Gal-9) in breast cancer cells. Immunohistochemical (IHC) staining was used to evaluate changes in PD-L1 and Gal-9 expression in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dcb7e4c33dc2d370dc800f0eef7c7b8
https://pubmed.ncbi.nlm.nih.gov/30139555
https://pubmed.ncbi.nlm.nih.gov/30139555